17905371|t|Neurological complications of Schistosoma infection.
17905371|a|Schistosomiasis is a parasitic disease caused by blood flukes of the genus Schistosoma. Currently more than 200 million people worldwide are affected. Neuroschistosomiasis constitutes a severe presentation of the disease. Neurological symptoms result from the inflammatory response of the host to egg deposition in the brain and spinal cord. Neurological complications of cerebral schistosomiasis include delirium, loss of consciousness, seizures, dysphasia, visual field impairment, focal motor deficits and ataxia. Cerebral and cerebellar tumour-like neuroschistosomiasis can present with increased intracranial pressure, headache, nausea and vomiting, and seizures. Myelopathy (acute transverse myelitis and subacute myeloradiculopathy) is the most common neurological complication of Schistosoma mansoni infection. Schistosomal myelopathy tends to occur early after infection and is more likely to be symptomatic than cerebral schistosomiasis. The conus medullaris and cauda equina are the most common sites of involvement. Severe schistosomal myelopathy can provoke a complete flaccid paraplegia with areflexia, sphincter dysfunction and sensory disturbances. Schistosomicidal drugs, steroids and surgery are the currently available treatments for neuroschistosomiasis. Rehabilitation and multidisciplinary team care are needed in severely disabled patients.
17905371	0	26	Neurological complications	Disease	MESH:D002493
17905371	30	51	Schistosoma infection	Disease	MESH:D012555
17905371	53	68	Schistosomiasis	Disease	MESH:D012552
17905371	128	139	Schistosoma	Species	6181
17905371	204	224	Neuroschistosomiasis	Disease	MESH:D020818
17905371	275	296	Neurological symptoms	Disease	MESH:D009461
17905371	313	325	inflammatory	Disease	MESH:D007249
17905371	395	421	Neurological complications	Disease	MESH:D002493
17905371	425	449	cerebral schistosomiasis	Disease	MESH:D012552
17905371	458	466	delirium	Disease	MESH:D003693
17905371	468	489	loss of consciousness	Disease	MESH:D014474
17905371	491	499	seizures	Disease	MESH:D012640
17905371	501	510	dysphasia	Disease	MESH:D001037
17905371	512	535	visual field impairment	Disease	MESH:D005128
17905371	537	557	focal motor deficits	Disease	MESH:D009461
17905371	562	568	ataxia	Disease	MESH:D001259
17905371	570	601	Cerebral and cerebellar tumour-	Disease	MESH:D002528
17905371	606	626	neuroschistosomiasis	Disease	MESH:D020818
17905371	644	675	increased intracranial pressure	Disease	MESH:D019586
17905371	677	685	headache	Disease	MESH:D006261
17905371	687	706	nausea and vomiting	Disease	MESH:D020250
17905371	712	720	seizures	Disease	MESH:D012640
17905371	722	732	Myelopathy	Disease	MESH:D020818
17905371	740	759	transverse myelitis	Disease	MESH:D009188
17905371	773	791	myeloradiculopathy	Disease	MESH:D020818
17905371	812	837	neurological complication	Disease	MESH:D002493
17905371	841	870	Schistosoma mansoni infection	Disease	MESH:D012555
17905371	872	895	Schistosomal myelopathy	Disease	MESH:D020818
17905371	923	932	infection	Disease	MESH:D007239
17905371	975	999	cerebral schistosomiasis	Disease	MESH:D012552
17905371	1088	1111	schistosomal myelopathy	Disease	MESH:D020818
17905371	1135	1153	flaccid paraplegia	Disease	MESH:D010264
17905371	1159	1168	areflexia	Disease	MESH:D000071699
17905371	1170	1191	sphincter dysfunction	Disease	MESH:D046628
17905371	1196	1216	sensory disturbances	Disease	MESH:D012678
17905371	1242	1250	steroids	Chemical	MESH:D013256
17905371	1306	1326	neuroschistosomiasis	Disease	MESH:D020818
17905371	1407	1415	patients	Species	9606
17905371	Negative_Correlation	MESH:D013256	MESH:D010264
17905371	Negative_Correlation	MESH:D013256	MESH:D012678
17905371	Negative_Correlation	MESH:D013256	MESH:D000071699
17905371	Negative_Correlation	MESH:D013256	MESH:D020818

